Kumari Ritu, Kumar Rakesh, Muni Sweta, Kumar Shailesh, Kumari Namrata
Microbiology, Indira Gandhi Institute of Medical Sciences, Patna, IND.
Cureus. 2024 Mar 6;16(3):e55688. doi: 10.7759/cureus.55688. eCollection 2024 Mar.
Background Tuberculosis (TB) remains a global health concern, with India bearing a substantial burden. Paediatric TB, especially extrapulmonary TB (EPTB), presents unique diagnostic challenges due to its paucibacillary nature and the difficulty in obtaining suitable samples in children. Accurate and timely diagnosis is crucial to initiate appropriate treatment and mitigate disease spread. The MPT64 antigen test has shown promise in diagnosing TB, but its performance in paediatric EPTB remains underexplored. This study aimed to evaluate the diagnostic utility of the MPT64 antigen test in paediatric EPTB cases at a tertiary care hospital in India. Methods We conducted a prospective cross-sectional study at the Indira Gandhi Institute of Medical Sciences (IGIMS), a tertiary care hospital in India. A total of 250 paediatric participants, aged 0-18 years, with clinical suspicion of extrapulmonary tuberculosis (EPTB) were included. Diagnostic samples (e.g., tissue biopsies, pus, cerebrospinal fluid (CSF), and lymph node aspirates) were obtained, and tests including microscopy for acid-fast bacilli (AFB), mycobacterial cultures, GeneXpert MTB/RIF assay, and the TB Antigen MPT64 Rapid ICT Kit were performed. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy of the MPT64 antigen test were calculated using culture and GeneXpert as reference standards. Results Among the 250 participants, 34 (13.6%) were confirmed to have EPTB. The MPT64 antigen test demonstrated a sensitivity of 70.6% and specificity of 92.1% in detecting EPTB cases. Mycobacterial cultures had the highest sensitivity (91.2%) and specificity (97.7%). GeneXpert showed a sensitivity of 70.6% and specificity of 93.9%. Overall diagnostic accuracy ranged from 88.7% for acid-fast bacteria (AFB) staining to 96.9% for mycobacterial cultures. The MPT64 antigen test had an area under the curve (AUC) of 0.814, indicating a good diagnostic accuracy. Conclusion The MPT64 antigen test demonstrates promising sensitivity and specificity for diagnosing paediatric EPTB, making it a valuable diagnostic tool, especially in resource-limited settings. However, mycobacterial cultures maintain the highest accuracy. Combining the MPT64 antigen test with other methods may enhance diagnostic capabilities.
结核病仍是全球关注的健康问题,印度负担沉重。儿童结核病,尤其是肺外结核病(EPTB),因其菌量少以及在儿童中获取合适样本困难而带来独特的诊断挑战。准确及时的诊断对于启动适当治疗和减轻疾病传播至关重要。MPT64抗原检测在结核病诊断中显示出前景,但其在儿童EPTB中的表现仍未得到充分探索。本研究旨在评估MPT64抗原检测在印度一家三级医院的儿童EPTB病例中的诊断效用。
我们在印度一家三级医院英迪拉·甘地医学科学研究所(IGIMS)进行了一项前瞻性横断面研究。共纳入250名年龄在0至18岁、临床怀疑患有肺外结核病(EPTB)的儿童参与者。获取诊断样本(如组织活检、脓液、脑脊液(CSF)和淋巴结抽吸物),并进行包括抗酸杆菌(AFB)显微镜检查、分枝杆菌培养、GeneXpert MTB/RIF检测以及TB抗原MPT64快速免疫层析检测试剂盒在内的检测。以培养和GeneXpert作为参考标准,计算MPT64抗原检测的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和诊断准确性。
在250名参与者中,34人(13.6%)被确诊患有EPTB。MPT64抗原检测在检测EPTB病例时显示出70.6%的敏感性和92.1%的特异性。分枝杆菌培养的敏感性最高(91.2%),特异性为97.7%。GeneXpert的敏感性为70.6%,特异性为93.9%。总体诊断准确性范围从抗酸菌(AFB)染色的88.7%到分枝杆菌培养的96.9%。MPT64抗原检测的曲线下面积(AUC)为0.814,表明诊断准确性良好。
MPT64抗原检测在诊断儿童EPTB方面显示出有前景的敏感性和特异性,使其成为一种有价值的诊断工具,尤其是在资源有限的环境中。然而,分枝杆菌培养的准确性最高。将MPT64抗原检测与其他方法结合可能会提高诊断能力。